Rapid Micro Biosystems reported a quarterly loss of $0.27/share, slightly better than the Zacks Consensus Estimate of a $0.26 loss, and matching last year’s $0.27 loss. The near-consensus result suggests limited new directional information for investors.
Rapid Micro Biosystems reported a quarterly loss of $0.27/share, slightly better than the Zacks Consensus Estimate of a $0.26 loss, and matching last year’s $0.27 loss. The near-consensus result suggests limited new directional information for investors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
